Difference between revisions of "Eluvixtamab (AMG-330)"
Jump to navigation
Jump to search
m |
m |
||
| Line 11: | Line 11: | ||
[[Category:T-cell activators]] | [[Category:T-cell activators]] | ||
| − | [[Category:BiTE antibodies]] | + | [[Category:Anti-CD33 BiTE antibodies]] |
[[Category:Anti-CD33 antibodies]] | [[Category:Anti-CD33 antibodies]] | ||
[[Category:Anti-CD3 antibodies]] | [[Category:Anti-CD3 antibodies]] | ||
[[Category:Investigational drugs]] | [[Category:Investigational drugs]] | ||
Revision as of 15:09, 28 June 2023
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3
Also known as
- Code name: AMG 330